• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[脓毒症最新进展:定义与流行病学]

[Sepsis Update: Definition and Epidemiology].

作者信息

Bracht Hendrik, Hafner Sebastian, Weiß Manfred

出版信息

Anasthesiol Intensivmed Notfallmed Schmerzther. 2019 Jan;54(1):10-20. doi: 10.1055/a-0625-5492. Epub 2019 Jan 8.

DOI:10.1055/a-0625-5492
PMID:30620952
Abstract

Sepsis is a common disease in intensive care units worldwide, which is associated with relevant morbidity and mortality. Although massive research efforts have been made for decades, there is no specific therapy for sepsis to date. Decisive in the treatment of sepsis is the early diagnosis, because the outcome of the treated patients can be significantly improved by early elimination of the infection focus, the fastest possible administration of a broad, calculated antibiosis as well as the stabilization of the hemodynamic situation. A definition of the clinical picture of sepsis with high diagnostic sensitivity and specificity is therefore indispensable. This article describes the previously and the currently available definition of sepsis and gives an overview of the epidemiology of this disease.

摘要

脓毒症是全球重症监护病房中的常见疾病,与相关的发病率和死亡率相关。尽管数十年来已进行了大量研究工作,但迄今为止仍没有针对脓毒症的特效疗法。脓毒症治疗的关键在于早期诊断,因为通过尽早消除感染源、尽快给予广泛且合理的抗生素治疗以及稳定血流动力学状况,可显著改善患者的治疗结局。因此,具备高诊断敏感性和特异性的脓毒症临床表现定义不可或缺。本文介绍了脓毒症先前和当前可用的定义,并概述了该疾病的流行病学情况。

相似文献

1
[Sepsis Update: Definition and Epidemiology].[脓毒症最新进展:定义与流行病学]
Anasthesiol Intensivmed Notfallmed Schmerzther. 2019 Jan;54(1):10-20. doi: 10.1055/a-0625-5492. Epub 2019 Jan 8.
2
The systemic inflammatory response, sepsis, and multiple organ dysfunction: new definitions for an old problem.全身炎症反应、脓毒症及多器官功能障碍:一个老问题的新定义
Crit Care Nurs Clin North Am. 1994 Jun;6(2):243-50.
3
Classification, incidence, and outcomes of sepsis and multiple organ failure.脓毒症及多器官功能衰竭的分类、发病率和结局
Contrib Nephrol. 2007;156:64-74. doi: 10.1159/000102071.
4
Epidemiology of severe sepsis in the intensive care unit.重症监护病房中严重脓毒症的流行病学
Br J Hosp Med (Lond). 2008 Aug;69(8):442-3. doi: 10.12968/hmed.2008.69.8.30739.
5
Let's agree on terminology: definitions of sepsis.
Crit Care Med. 1991 Jul;19(7):973-6. doi: 10.1097/00003246-199107000-00024.
6
20 Years On: Is It Time to Redefine the Systemic Inflammatory Response to Cardiothoracic Surgery?20年过去了:是时候重新定义对心胸外科手术的全身炎症反应了吗?
J Extra Corpor Technol. 2015 Mar;47(1):5-9.
7
Surgical Critical Care for the Patient with Sepsis and Multiple Organ Dysfunction.脓毒症和多器官功能障碍患者的外科重症监护
Anesthesiol Clin. 2016 Dec;34(4):681-696. doi: 10.1016/j.anclin.2016.06.005.
8
[Sepsis, terminology and nature (impressions and thoughts of a participant of a consensus conference)].[脓毒症,术语与本质(共识会议参与者的印象与思考)]
Vestn Khir Im I I Grek. 1999;158(3):86-8.
9
[Epistemology in the intensive care unit-what is the purpose of a definition? : Paradigm shift in sepsis research].[重症监护病房中的认识论——定义的目的是什么?:脓毒症研究中的范式转变]
Anaesthesist. 2017 Aug;66(8):622-625. doi: 10.1007/s00101-017-0315-3.
10
An evaluation of the diagnostic accuracy of the 1991 American College of Chest Physicians/Society of Critical Care Medicine and the 2001 Society of Critical Care Medicine/European Society of Intensive Care Medicine/American College of Chest Physicians/American Thoracic Society/Surgical Infection Society sepsis definition.1991 年美国胸科医师学会/危重病医学会和 2001 年危重病医学会/欧洲危重病医学学会/美国胸科医师学会/美国胸科学会/外科感染学会脓毒症定义的诊断准确性评估。
Crit Care Med. 2012 Jun;40(6):1700-6. doi: 10.1097/CCM.0b013e318246b83a.

引用本文的文献

1
Advancements, Challenges, and Future Prospects of Nanotechnology in Sepsis Therapy.纳米技术在脓毒症治疗中的进展、挑战与未来前景
Int J Nanomedicine. 2025 Jun 16;20:7685-7714. doi: 10.2147/IJN.S488026. eCollection 2025.
2
Role of GLP‑1 receptor agonists in sepsis and their therapeutic potential in sepsis‑induced muscle atrophy (Review).胰高血糖素样肽-1受体激动剂在脓毒症中的作用及其对脓毒症诱导的肌肉萎缩的治疗潜力(综述)
Int J Mol Med. 2025 May;55(5). doi: 10.3892/ijmm.2025.5515. Epub 2025 Mar 7.
3
SOFA in sepsis: with or without GCS.SOFA 在脓毒症中的应用:是否联合 GCS。
Eur J Med Res. 2024 May 24;29(1):296. doi: 10.1186/s40001-024-01849-w.
4
Low-dose PLX5622 treatment prevents neuroinflammatory and neurocognitive sequelae after sepsis.低剂量 PLX5622 治疗可预防脓毒症后的神经炎症和神经认知后遗症。
J Neuroinflammation. 2023 Dec 1;20(1):289. doi: 10.1186/s12974-023-02975-8.
5
Value of IL-1β and IL-23 in Predicting 28-Day Mortality Due to Sepsis: A Retrospective Study.白细胞介素-1β 和白细胞介素-23 对预测脓毒症 28 天病死率的价值:一项回顾性研究。
Med Sci Monit. 2023 May 21;29:e940163. doi: 10.12659/MSM.940163.
6
Diagnostic value of RDW for the prediction of mortality in adult sepsis patients: A systematic review and meta-analysis.RDW 对成人脓毒症患者死亡率预测的诊断价值:系统评价和荟萃分析。
Front Immunol. 2022 Oct 17;13:997853. doi: 10.3389/fimmu.2022.997853. eCollection 2022.
7
The association between continuous renal replacement therapy as treatment for sepsis-associated acute kidney injury and trend of lactate trajectory as risk factor of 28-day mortality in intensive care units.连续性肾脏替代疗法治疗脓毒症相关性急性肾损伤与重症监护病房 28 天死亡率乳酸轨迹趋势的关系。
BMC Emerg Med. 2022 Feb 28;22(1):32. doi: 10.1186/s12873-022-00589-6.
8
Diagnostic Value of sIL-2R, TNF-α and PCT for Sepsis Infection in Patients With Closed Abdominal Injury Complicated With Severe Multiple Abdominal Injuries.sIL-2R、TNF-α 和 PCT 对合并严重多发腹部损伤的闭合性腹部损伤患者感染性休克的诊断价值。
Front Immunol. 2021 Oct 22;12:741268. doi: 10.3389/fimmu.2021.741268. eCollection 2021.
9
Diagnostic value of monocyte chemoattractant Protein-1, soluble mannose receptor, Presepsin, and Procalcitonin in critically ill children admitted with suspected sepsis.单核细胞趋化蛋白-1、可溶性甘露糖受体、降钙素原和 Presepsin 在疑似脓毒症危重症患儿中的诊断价值。
BMC Pediatr. 2021 Oct 19;21(1):458. doi: 10.1186/s12887-021-02930-7.
10
MiR-940 Serves as a Diagnostic Biomarker in Patients with Sepsis and Regulates Sepsis-Induced Inflammation and Myocardial Dysfunction.微小RNA-940作为脓毒症患者的诊断生物标志物并调节脓毒症诱导的炎症反应和心肌功能障碍。
J Inflamm Res. 2021 Sep 9;14:4567-4574. doi: 10.2147/JIR.S316169. eCollection 2021.